Inmune Bio (INMB) Market Capitalization (2019 - 2026)
Inmune Bio (INMB) posted Market Capitalization of $45.08 million for Q2 2026, down 26.6% from $61.41 million a year earlier but up 50.0% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Market Capitalization (2019 - 2026) Analysis & Trends
For FY2025, Inmune Bio's Market Capitalization came in at $41.47 million, down 60.1% from FY2024.
- Annual Market Capitalization shows a five-year compound annual growth rate of -29.1% (FY2020 to FY2025).
- In prior years, Inmune Bio's Market Capitalization was $104.05 million in FY2024 (-48.5%), $202.13 million in FY2023 (+77.6%), $113.78 million in FY2022 (-37.5%) and $182 million in FY2021 (-21.6%).
- Quarterly Market Capitalization has run from a low of $30.04 million in Q1 2026 to a high of $346.52 million in Q3 2021 over five years.
- On a year-over-year basis, Market Capitalization has declined in each of the last eight quarters, with an average decline of 44.2% over the last eight quarters.
- The strongest year-over-year quarter for Market Capitalization in the past five years was Q3 2021, with growth of 149.9%; the weakest was Q1 2026, with a decline of 83.2%.
- According to Business Quant data, Market Capitalization for the three prior quarters was $30.04 million (Q1 2026), $41.47 million (Q4 2025) and $55.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Inmune Bio | 42.88 Mn | -49.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.08 Mn |
| Mar 31, 2026 | 30.04 Mn |
| Dec 31, 2025 | 41.47 Mn |
| Sep 30, 2025 | 55.03 Mn |
| Jun 30, 2025 | 61.41 Mn |
| Mar 31, 2025 | 179.09 Mn |
| Dec 31, 2024 | 104.05 Mn |
| Sep 30, 2024 | 119.51 Mn |
| Jun 30, 2024 | 173.81 Mn |
| Mar 31, 2024 | 210.92 Mn |
| Dec 31, 2023 | 202.13 Mn |
| Sep 30, 2023 | 121.49 Mn |
| Jun 30, 2023 | 162.95 Mn |
| Mar 31, 2023 | 115.93 Mn |
| Dec 31, 2022 | 113.78 Mn |
| Sep 30, 2022 | 111.27 Mn |
| Jun 30, 2022 | 158.64 Mn |
| Mar 31, 2022 | 151.11 Mn |
| Dec 31, 2021 | 182.00 Mn |
| Sep 30, 2021 | 346.52 Mn |
API Access
Inmune Bio Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();